A Novel Approach to Controlling Secondary Hyperparathyroidism (HPT): Targeting the Calcium-Sensing Receptor

ASN Renal Week, Official Evening Symposium
San Diego, CA, November, 2003
Introduction
William Goodman, MD; Esther Gonzalez, MD (moderators)

Challenges in Secondary Hyperparathyrodism (HPT) and the New K/DOQI Targets
Kevin Martin, MB, BCh, FACP

Regulation of Parathyroid Functions by Calcimimetic Compounds
Edward Nemeth, PhD

Cinacalcet HCl in Controlling Secondary HPT: Phase 3 Results
Geoffrey Block, MD
Questions and Answers
Speakers and moderators



Geoffrey Block, MD
Director of Clinical Research
Denver Nephrologists, PC
Denver, CO

Esther Gonzalez, MD
Assistant Professor of Internal Medicine
Saint Louis University School of Medicine
St. Louis, MO

William Goodman, MD
Professor of Medicine in the Division of Nephrology
UCLA School of Medicine
Los Angeles, CA

Kevin Martin, MB, BCh, FACP

Professor of Internal Mediciine
Director, Division of Nephrology
Saint Louis University
St. Louis, MO

Eward Nemeth, PhD
Chief Scientific Officer
NPS Pharmaceuticals, Inc.
Toronto, Ontario, Canada

This group of talks is accredited for up to 2.0 CME Category 1 credits by the American Society of Nephrology. This group of talks has a single post-test, which must be completed along with an evaluation form to obtain Category 1 credit. The links to the post-test appear on the individual talk pages.
Date of Web Release: May 1, 2004
CME Credit Eligible Through: May 1, 2005
CME Category 1 Credits/Completion Time: 2.0
Target Audiences: Nephrology Board and Recertification candidates practicing nephrologists and internists.
Method of participation: Listen to the talk, read the PubMed abstracts linked to data slides and talk references, take the post-test, read the abstracts linked to post-test answer feedback material.

STATEMENT OF NEED :
Chronic kidney disease affects 30-40 million Americans, of whom several thousand require renal replacement therapy. These selected lectures are chosen by the HDCN editor and ASN Postgraduate Medical Director to reflect those areas of practice of greatest interest to the clinician, and areas where recent progress has occurred. The web extension of these ASN lectures will allow nephrologists and other physicians who were unable to attend the live sessions to gain similar benefit from these presentations.
ACCREDITATION STATEMENT:
Accreditation Statement
The American Society of Nephrology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The American Society of Nephrology designates this educational activity for a maximum of 2.0 hours of category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the activity.

The American Medical Association has determined that non-US licensed physicians who participate in this CME activity are eligible for AMA PRA category 1 credit.
SPONSORSHIP / SUPPORT :
This official evening symposium was sponsored by an educational grant from Amgen, Inc.
FACULTY DISCLOSURE STATEMENTS :
American Society of Nephrology as well as HDCN have conflict of interest policies that requires course faculty to disclose any real or apparent commercial financial affiliations related to the content of their presentations/materials. It is not assumed that these financial interests or affiliations will have an adverse impact on faculty presentations; they are simply noted here to fully inform participants. Speaker disclosures are posted on each individual talk page.
DISCLOSURE OF UNLABELED USE:
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by FDA. The American Society of Nephrology and HDCN do not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. Speaker disclosure about individual talks is posted on each individual talk page.

DISCLAIMER:
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

USER INSTRUCTIONS:
To complete this educational activity, the user will need Windows or Macintosh operating software, a connection to the internet with a 28.8 kbps MODEM or better. The computer should have an audio card with speakers. An audio player, either the Windows Media Player from Microsoft or the Real Player from Real Media (www.real.com) is required and either can be downloaded for free per instructions on the individual lecture pages. Acrobat Reader is required to print the CME certificate, and this can be download free from www.adobe.com.

For any questions concerning this specific activity please send an email to or email@asn-online.org, or call HDCN at 630-325-3276.

For any general questions concerning ASN CME, please contact the American Society of Nephrology.